Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Debt / NOTE 1.750% 6/1
-
Number of holders
-
49
-
Total 13F principal, excl. options
-
524,377,000
-
Principal change
-
-18,705,999
-
Total reported value, excl. options
-
$551,732,968
-
Value change
-
-$19,984,608
-
Number of buys
-
21
-
Number of sells
-
-19
-
Price
-
$1.05
Significant Holders of IONIS PHARMACEUTICALS INC - NOTE 1.750% 6/1 as of Q2 2025
52 filings reported holding 462222AF7 - IONIS PHARMACEUTICALS INC - NOTE 1.750% 6/1 as of Q2 2025.
IONIS PHARMACEUTICALS INC - NOTE 1.750% 6/1 has 49 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $524,377,000 of principal
.
Largest 10 bondholders include Voya Investment Management LLC ($74,965,000 of principal), CAMDEN ASSET MANAGEMENT L P /CA ($74,661,000 of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($46,696,000 of principal), LAZARD ASSET MANAGEMENT LLC ($41,831,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($40,271,000 of principal), BlackRock, Inc. ($28,725,000 of principal), WELLINGTON MANAGEMENT GROUP LLP ($28,697,000 of principal), MACKAY SHIELDS LLC ($27,793,000 of principal), Calamos Advisors LLC ($25,674,000 of principal), and MORGAN STANLEY ($15,030,000 of principal).
This table shows the top 49 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.